Bedaquiline Fumarate Patent Expiration

Bedaquiline Fumarate is Used for treating pulmonary multi-drug resistant tuberculosis. It was first introduced by Janssen Therapeutics Div Janssen Products Lp in its drug Sirturo on Dec 28, 2012.

Bedaquiline Fumarate Patents

Given below is the list of patents protecting Bedaquiline Fumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Sirturo US7498343 Mycobacterial inhibitors Dec 01, 2026 Janssen Therap
Sirturo US8546428 Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol Mar 19, 2029 Janssen Therap

Coming Soon

Patent Strength Analyzer

Will this be useful for you?


Thank you for your response 🥳